U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07303517) titled 'AI-Driven Consent Simplification Study' on Dec. 08.
Brief Summary: The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses.
Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving...